GETINGE is a leading global provider of equipment and systems to customers within health care and pharmaceutical industries/laboratories.
Quote | Getinge AB ADR (OTCMKTS:GNGBY)
Last: | $19.43 |
---|---|
Change Percent: | -1.74% |
Open: | $19.32 |
Close: | $19.43 |
High: | $19.46 |
Low: | $19.268 |
Volume: | 5,252 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Getinge AB ADR (OTCMKTS:GNGBY)
2024-02-01 10:04:05 ET Getinge AB (publ) (GNGBF) Q4 2023 Earnings Conference Call February 1, 2024 4:00 am ET Company Participants Mattias Perjos - President and CEO Lars Sandstrom - CFO Conference Call Participants Erik Cassel - Danske Bank Oliver Re...
Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...
Message Board Posts | Getinge AB ADR (OTCMKTS:GNGBY)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $GNGBY News Article - Getinge recieves FDA premarket approval for the iCast(TM) covered | whytestocks | investorshangout | 03/24/2023 8:00:50 PM |
whytestocks: $GNGBY News Article - Getinge Q3 Report 2021: "Strong order intake and our remediation | whytestocks | investorshangout | 10/20/2021 5:55:50 PM |
whytestocks: $GNGBY News Article - The ventilation technology from Getinge that is groundbreaking bo | whytestocks | investorshangout | 09/30/2020 1:55:53 PM |
whytestocks: $GNGBY News Article - Getinge Interim Report January-June 2020: Making a Real Differenc | whytestocks | investorshangout | 07/16/2020 6:10:48 PM |
Emylers: GNGBY Financials 07/16/2014 06:52:37 Getinge Industrier AB Period Ending Total Revenue Cost | Emylers | investorshangout | 07/16/2014 11:52:34 AM |
News, Short Squeeze, Breakout and More Instantly...
Getinge AB ADR Company Name:
GNGBY Stock Symbol:
OTCMKTS Market:
Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...
Greif Inc. Class A (GEF) is expected to report $1.3 for Q4 2023 Skandinaviska Enskilda Banken - Class A (SVKEF) is expected to report for Q3 2023 Yellow Corporation (YELLQ) is expected to report for Q3 2023 Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Lakeland Industrie...
Addex Therapeutics Ltd (ADXN) is expected to report $-4 for Q3 2023 Eco Wave Power Global AB (publ) (WAVE) is expected to report for quarter end 2023-09-30 AmeraMex International, Inc. (AMMX) is expected to report for Q3 2023 iClick Interactive Asia Group Limited (ICLK) is expected to...